title: Sjögren's syndrome.
abstract: Saliva is an essential body fluid. It is important in maintaining oral health, taste acuity, mastication, deglutition and digestion, oral flora regulation, oral cleansing, voice acuity, and speech articulation. Saliva is composed largely of water but also contains minerals, electrolytes, buffers, enzymes, growth factors, cytokines, immunoglobulins, proteins, and metabolic waste products, with the concentrations and compositions of these components varying by individual. Many systemic disorders can affect salivary function, greatly compromising oral health. One such disorder is Sjögren's Syndrome (SS), an autoimmune exocrinopathy characterized by oral and ocular dryness with or without impairment of other organ systems. SS can cause substantial serologic autoimmune reactivity and in some instances is associated with other connective-tissue autoimmune disorders, such as rheumatoid arthritis, scleroderma, or systemic lupus erythematosus. SS increases the risk for developing malignant non-Hodgkin's lymphoma. Treatment of this syndrome consists of a combination of multiple agents, depending on the degree of symptomatology: cholinergic agonists, artificial salivary substitutes, nonsteroidal anti-inflammatory agents, antirheumatic drugs, and biologic agents. This article describes saliva and salivary function, the pathogenesis of SS, the current treatment of xerostomia, and quality of life issues related to salivary dysfunction.
authors.affiliation: Department of Head and Neck Surgery, The University of Texas, M.D. Anderson Cancer Center, Houston 77030-4009, USA. mchambers@mdanderson.org
authors.forename: Mark S
authors.initials: MS
authors.lastname: Chambers
mesh_terms: D018679:Cholinergic Agonists / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D024802:Nurse's Role; D010348:Patient Care Team / Q000458:organization & administration; D010353:Patient Education as Topic; D012307:Risk Factors; D012463:Saliva / Q000502:physiology; D012464:Saliva, Artificial / Q000627:therapeutic use; D012469:Salivary Glands / Q000503:physiopathology; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D014985:Xerophthalmia / Q000209:etiology; D014987:Xerostomia / Q000209:etiology
chemical_list: D018679:Cholinergic Agonists; D012464:Saliva, Artificial